swingtrade_secrets

laurus labs EMA cross over DAILY CHART

Long
NSE:LAURUSLABS   LAURUS LABS LTD
Laurus Labs (LAURUS)’s Annual Report Analysis indicates a sharp improvement in
ROE, led by a strong head-start in Finished dosage forms (FDF), improving operating
profit, and a reduced interest rate, the brokerages have upgraded their target as well;

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.